Michael H. Carrel - 30 Jun 2025 Form 4 Insider Report for AtriCure, Inc. (ATRC)

Role
President, CEO, & Director, Director
Signature
/s/ Allison Walker as Attorney-in-fact for Michael H. Carrel
Issuer symbol
ATRC
Transactions as of
30 Jun 2025
Net transactions value
+$21,240
Form type
4
Filing time
02 Jul 2025, 08:48:49 UTC
Previous filing
12 Mar 2025
Next filing
12 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CARREL MICHAEL H President, CEO, & Director, Director 7555 INNOVATION WAY, MASON /s/ Allison Walker as Attorney-in-fact for Michael H. Carrel 02 Jul 2025 0001230584

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRC Common Stock Award $21,240 +822 +0.12% $25.84 707,377 30 Jun 2025 Direct F1, F2
holding ATRC Common Stock 9,310 30 Jun 2025 Held by reporting person's children F3
holding ATRC Common Stock 2,250 30 Jun 2025 Held by reporting person's parents F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2025.
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 2, 2025, which is the first trading day of the applicable offering period. The closing price on January 2, 2025 was $30.40.
F3 The reporting person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.